NCT01676987View on ClinicalTrials.gov

Evaluation of the Efficacy and Safety of a Fixed-dose, Single-capsule Budesonide-formoterol Combination in Uncontrolled Asthma

PHASE3CompletedINTERVENTIONAL
Enrollment

181

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

September 30, 2010

Study Completion Date

June 30, 2011

Conditions
Asthma
Interventions
DRUG

Fixed combination of budesonide and formoterol

Delivered dry powder inhaler for 12 weeks.

DRUG

Budesonide

Delivered dry powder inhaler for 12 weeks.

Sponsors
All Listed Sponsors
lead

Ache Laboratorios Farmaceuticos S.A.

INDUSTRY